In this episode of Eye.Talk.Tech, Dr. Griffin Christenson welcomes Michael Gatti and Warren Modlin to discuss the technology behind HOYA’s Sensity 3 photochromic lenses, the newest addition to the Sensity Family coming April 2026. They discuss the research behind faster fade-back speeds and improved durability. The conversation highlights the importance of understanding patient lifestyles and delivering personalized lens recommendations. The episode also explores HOYA’s innovation strategy and shares key details about the upcoming product launch.Key TakeawaysPhotochromic lenses are evolving to meet patient demands.Sensity 3 offers a balance between strength and dynamic range.The resilience index measures lens durability and adaptability.HOYA focuses on delivering value through innovative lens technology.The launch of Sensity 3 is a significant advancement in optics.Future iterations of photochromic lenses are in development. Guest Bios Michael Gatti is an Arizona state licensed, ABO and NCLE certified optician, and the Senior Manager of Professional Engagement at HOYA Vision Care. With over 20 years in the optical industry, Michael is an international speaker who has energized audiences across North America with his dynamic storytelling, practical insight, and motivational content. Known for turning complex topics into clear, actionable takeaways, he inspires eye care professionals to embrace change and drive growth in their practices.Warren Modlin has spent over 30 years at the intersection of vision science, product innovation, and business strategy. He began his career as an optometrist and has held global leadership roles at HOYA, Oakley, and Alcon. He is also the founder of NDV Performance, a neurodynamic vision training platform.Chapters00:00 Introduction to Sensity 3 Launch02:50 Trends in Photochromic Lenses05:56 Technological Innovations in Sensity 308:56 Patient Experience and Comfort11:37 The Science Behind Sensity 314:48 Addressing Patient Needs17:49 HOYA's Vision and Market Position20:45 Next Steps for Clinicians23:56 Conclusion and Future OutlookFurther Resources 🔗Learn more about http://www.hoyavision.us/ 🌐 connect → https://www.linkedin.com/in/modsmark/ and https://www.linkedin.com/in/michael-gatti-360001184/↓Download Sensity 3 Sales Aid → https://drive.google.com/file/d/1nGuYp-s2gu1T0FFMEs-ky0rjZWEdEfYq/view?usp=sharing 🎧Listen on Spotify → 🔔 Subscribe for more Eye.Talk.Tech. → https://www.youtube.com/@Fluorescene#EyeTalkTech #ODsonTechnology #ODsOnFacebook #HOYA #Sensity3 #LensInnovation #PhotochromicLenses #PatientExperience #LensTechnology #OptometryInnovation #Optometry #FutureOfEyeCare #FluoresceneGroup___________________________About the podcastEye.Talk.Tech. is an eye tech education podcast series that brings subject matter experts and real conversations to the intersection of eye care and technology. Each episode explores innovations and future trends that matter to eyecare professionals worldwide. It is hosted by Dr. Griffin Christenson, OD, MS CS - Interactive Intelligence, It’s the flagship videocast of ODs on Technology - a public platform hosting eye tech content, research, and breakthroughs. Visit us at www.odsontechnology.comWho are we___________________________DisclaimerThis episode is for informational purposes only and not medical advice. Always consult a licensed eye care professional. Guest views are their own and do not reflect those of the host, FluoreSCENE Group, or partners. Mentions of products, tech, or treatments are not endorsements and may include off-label or investigational use. Emerging technologies discussed (e.g., AI, digital tools) may be unapproved and evolving. Use clinical judgment before adopting them.